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Summary
Objective: The aim of the present study was to investi-
gate the relationship between the differential expres-
sion of genes related to lipid metabolism in subcutane-
ous adipose tissue and metabolic syndrome features in 
lean and obese subjects with habitual high fat intake. 
Methods: Microarray and RT-PCR analysis were used to 
analyze and validate differential gene expression in sub-
cutaneous abdominal adipose tissue samples from lean 
and obese phenotype subjects. Results: Several genes 
and transcripts involved in lipolysis were down-regu-
lated, such as AKAP1, PRKAR2B, Gi and CIDEA, whereas 
NPY1R and CES1 were up-regulated, when comparing 
obese to lean subjects. Similarly, transcripts associated 
with cholesterol and lipoprotein metabolism showed 
a differential expression, with APOE and ABCA being 
decreased and VLDLR being increased in obese versus 
lean subjects. In addition, positive correlations were 
found between different markers of the metabolic syn-
drome and CES1 and NPY1R mRNA expressions, while 
APOE showed an inverse association with some of them. 
Conclusion: Different expression patterns in transcripts 
encoding for proteins involved in lipolysis and lipopro-
tein metabolism were found between lean and obese 
subjects. Moreover, the dysregulation of genes such as 
CES1 and APOE seems to be associated with some phys-
iopathological markers of insulin resistance and cardio-
vascular risk factors in obesity. 
Introduction
Adiposetissueplaysacriticalrole inenergyhomeostasisby








portionate release of fatty acids and an impairment in the
secretionofadipokines[2].Ontheotherhand,lipodystrophy
mayalsoleadtophysiopathologicalalterationsoftenaccom-
panying themetabolic syndrome [3]. The common link be-





to a chronically disturbed energy balance could result in
changesinadipokinesecretionandvasculareffectsthatinflu-
encesthebodyhomeostasissystem,whichhasbeenproposed
as an explanation of the metabolic syndrome [5]. Further-
more,variationsinthenatureandmagnitudeoftheappear-
anceofthemetabolicsyndromemanifestationsareattributa-
ble to the interactionof genetic factorswith environmental
influences,mostnotablydietandphysicalactivity[6,7].
In this context,we investigated the relationship between





remained lean andwithno features ofmetabolic syndrome
and the other group was obese. Indeed, elucidating differ-
encesingeneexpressioninthesubcutaneousabdominaladi-
pose tissue (SCAAT) from these two groups of volunteers
could help to develop therapies to prevent metabolic
syndrome.
Subjects and Methods
Study Design and Subjects 
Ninelean(22–33yearsold)and9age-matchedobesehigh-fatconsumers









Toquantify the levelofphysical activity, eachparticipant completeda
validatedquestionnaire[9]basedonself-reportedquestionsabouttheir
leisuretimeandtheirworktimephysicalactivitiesonatypicalworkday
















Blood Pressure and Measurements 
Blood pressure (systolic and diastolic) was measured with a standard
mercurysphygmomanometer(MinimusII,Riester,Jungingen,Germany)
after the subjectwas quietly sitting for 5min followingWHOcriteria.
Fastingbloodmeasurementsweremadebystandardproceduresasprevi-




TotalRNAwas isolated fromeachhumanSCAATsample (including
adipocytes and stroma-vascular fraction) by homogenization with an
ultra-turrax®T25basicusingTRIzol(LifeTechnologies,Gaithersburg,
MD,USA)accordingtothemanufacturer’s instructionsandincubated
with RNase-free DNase (Ambion, Austin, TX, USA) for 30 min at
37°C.RNAconcentrationwasmeasuredspectrophotometrically,andits
quality was verified by ethidium bromide staining after agarose gel
electrophoresis.
Microarray Experiments and Analysis
RNAwaspooledtominimizethebiologicalvariationbetweentheindi-
vidualleanandobesesubjects.Thus,15mgoftotalRNAfromtwopools
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trix to label targets.These targets (biotinylated complementaryRNA)
were hybridized to the HumanHG-U133AGeneChip arrays (Affy-
metrix; SantaClara,CA,USA) at ProgenikaBiopharma Inc. (Derio-
Vizcaya,Spain),usingtoolsobtainedfromAffymetrixandaccordingto
themanufacturer’s protocol (Affymetrix).Thus, a total of 4 arrayhy-
bridizationswere performed. The obtained signal valueswere further
analyzedwiththeAffymetrixmicroarraysuite5.0.software(MAS5.0)






alteration ratiosof the geneexpressionwere representedasmeansof
SLRofthefourquotients[11].
GARBAN software [12, 13] was used to classify the differentially
expressedgenesaccordingtoGeneOntologybiologicalprocesscriteria.
Real-Time PCR Analysis 
Differentialgeneexpressionwasfurtherconfirmedbyreal-timePCRofa
subsetofgenesinindividualsamples(n=9ineachgroup).Reagentsfor
real-timePCRanalysisofAKAP1, NPY1R, CES1, APOE, VLDLRand


















Baseline Characteristics of Lean and Obese Subjects
Notsurprisinglywithrespecttothestudydesign,BMI,waist
circumference and waist-to-height ratio were significantly
higher in obese than in lean subjects. Insulin sensitivity re-
vealedbyQUICKIwassignificantlylowerinobesecompared
toleansubjects.Thefastinglipidprofile,includingtriglycer-
ides, total cholesterol and total / high-density lipoprotein
(HDL) cholesterol ratio, was significantly higher in obese
than in lean participants. The systolic and diastolic blood
pressure values were significantly elevated in obese when
comparedtoleansubjects.Moreover,theamountofleptinin









several transcripts related toTNF-a-induced lipolysiswere
down-regulated including Gi and CIDEA. In contrast,
CES1, an adipocyte lipase involved in basal lipolysis, was
up-regulated(table2). 
Inaddition,severaltranscriptsinvolvedincholesteroland
lipoprotein metabolism, e.g.APOE andABCA, a cellular
cholesteroltransporter,weredown-regulated(table2)while
VLDLRwas up-regulated in SCAAT in theobese subjects
(table2).
mRNA Expression of Selected Genes Correlated with Several 
Features of the Metabolic Syndrome 




waist circumference (r = 0.55; p = 0.032) and the waist-to-















levelswere inversely correlatedwith the cardiovascular risk
index(r=–0.65;p=0.009) (table3)andalsowithdiastolic
bloodpressure(r=–0.62;p=0.014).
AKAP1 mRNA levels were only significantly correlated
withthewaist-to-heightratio(–0.59;p=0.016)whilenosig-
nificant associations were found between VLDLR mRNA
levelsandmetabolicsyndromefeatures.
Microarray Data
The analysis of the microarray data revealed that several
relevanttranscriptsinvolvedinlipidmetabolismwerediffer-
entially expressed in SCAAT of obese and lean subjects
(table2).Somegenesinvolvedinthehormonallyregulated
lipolysis – AKAP1, PRKAR2B – were down-regulated,
whereasNPY1R was up-regulated (table 2).As expected,
Cholesterol Education Program, 5 of the obese volunteers
wereconsideredobesewithmetabolicsyndromebasedonthe
presence of three or more of the following characteristics:
waistcircumferencegreaterthan102cm,bloodpressureofat
least130/85mmHg,serumglucoselevelofatleast110mg/dl,
serum triacylglycerol level of at least 150 mg/dl and HDL
cholesterolleveloflessthan40mg/dl.
Lean(n=9) Obese(n=9) p
Energyintake,kcal/day 2,766.7±258.7 2,799.1±171.4 0.918
BMI,kg/m2 23.1±0.4 34.7±1.2 0.000
Waistcircumference,cm 78.7±1.2 105.7±2.6 0.000
Waist/heightratio 0.45±0.01 0.60±0.01 0.000
Leptin,ng/ml 8.3±2.6 33.3±4.6 0.000
Adiponectin,mg/ml 20.1±3.3 10.0±1.7 0.037
Glucose,mg/dl 90.3±3.9 92.7±2.3 0.070
QUICKI 0.40±0.00 0.35±0.01 0.004
Triglycerides,mg/dl 85.0±6.7 142.2±10.6 0.001
Totalcholesterol,mg/dl 167.4±17.7 188.5±6.3 0.008
HDLcholesterol,mg/dl 43.3±1.7 40.0±2.4 0.059
Total/HDLcholesterolratio 3.5±0.2 5.0±0.3 0.003
SBP,mmHg 122.5±3.6 139.1±2.8 0.002













Akinase(PRKA)anchorprotein1 AKAP1 –0.85±0.37 1.0±0.42 0.24±0.03*
Gprotein,ainhibitingactivitypolypeptide1 Gi –0.95±0.31
Phosphodiesterase3B PDE3B –0.85±0.55
NeuropeptideYreceptorY1 NPY1R 0.93±0.57 1.0±0.11 3.31±0.22*
Carboxylesterase1 CES1 0.80±0.50 1.0±0.14 1.86±0.17*
Celldeath-inducingDFFA-likeeffectorA CIDEA –1.13±0.38
Lipoprotein and cholesterol metabolism
ApolipoproteinE APOE –1.15±0.65 1.0±0.24 0.39±0.07**
ATP-bindingcassette,sub-familyA(ABC1) ABCA –0.63±0.21























related to lipid and cholesterol metabolism between obese
andleansubjectswithhabitualhigh-fatdietandphysicalac-
tivity, otherwise phenotypicallywell characterized [8],were
investigated. The analysis of anthropometrical and clinical
variablesoftheobesesubjectssuggestthattheyhaveahigher
riskfordevelopinginsulinresistance,hyperlipidemiaandcar-
diovascular disease,which are typical features of themeta-
bolicsyndrome.Indeed,5of theobesesubjects investigated
could be diagnosedwith metabolic syndrome according to
Adult Treatment Panel IIIandWorldHealthOrganization
criteria [6].However,newcriteria areunderdiscussion [14]
andmaychangetheassignment.Themechanismsunderlying
themetabolicsyndromearenotwellunderstood.Currentevi-
dence supports that the accumulation of abdominal fat is a
major determinant of themetabolic syndrome,while glute-
ofemoralbodyfatseemstoexertaprotectiverole[15].Up-
per-bodysubcutaneousfatisthedominantcontributortocir-
culating free fatty acids and themain sourceof excess fatty
acid release in upper-body obesity and of abnormalities in
subcutaneous lipolysis, which appears to be an important
cause of peripheral insulin resistance [16], possibly through
altering fat storage and the expression of TNF-a by adi-
pocytes in visceral fat [17].We investigated the differential









by A-kinase anchoring proteins (AKAPs) [20]. In fact,
AKAP1, identified as amajor adipocyte protein kinaseA-
binding protein [21],was down-regulated in obese subjects.
Wealso found that the transcriptionofNPY1R, apowerful
several transcripts related toTNF-a-induced lipolysiswere
down-regulated including Gi and CIDEA. In contrast,
CES1, an adipocyte lipase involved in basal lipolysis, was
up-regulated(table2). 
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Features of the Metabolic Syndrome 




waist circumference (r = 0.55; p = 0.032) and the waist-to-















levelswere inversely correlatedwith the cardiovascular risk
index(r=–0.65;p=0.009) (table3)andalsowithdiastolic
bloodpressure(r=–0.62;p=0.014).
AKAP1 mRNA levels were only significantly correlated
withthewaist-to-heightratio(–0.59;p=0.016)whilenosig-
nificant associations were found between VLDLR mRNA
levelsandmetabolicsyndromefeatures.
Microarray Data
The analysis of the microarray data revealed that several
relevanttranscriptsinvolvedinlipidmetabolismwerediffer-
entially expressed in SCAAT of obese and lean subjects
(table2).Somegenesinvolvedinthehormonallyregulated
lipolysis – AKAP1, PRKAR2B – were down-regulated,
whereasNPY1R was up-regulated (table 2).As expected,
Lean(n=9) Obese(n=9) p
Energyintake,kcal/day 2,766.7±258.7 2,799.1±171.4 0.918
BMI,kg/m2 23.1±0.4 34.7±1.2 0.000
Waistcircumference,cm 78.7±1.2 105.7±2.6 0.000
Waist/heightratio 0.45±0.01 0.60±0.01 0.000
Leptin,ng/ml 8.3±2.6 33.3±4.6 0.000
Adiponectin,mg/ml 20.1±3.3 10.0±1.7 0.037
Glucose,mg/dl 90.3±3.9 92.7±2.3 0.070
QUICKI 0.40±0.00 0.35±0.01 0.004
Triglycerides,mg/dl 85.0±6.7 142.2±10.6 0.001
Totalcholesterol,mg/dl 167.4±17.7 188.5±6.3 0.008
HDLcholesterol,mg/dl 43.3±1.7 40.0±2.4 0.059
Total/HDLcholesterolratio 3.5±0.2 5.0±0.3 0.003
SBP,mmHg 122.5±3.6 139.1±2.8 0.002
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r p r p r p
BMI,kg/m2 –0.68 0.006 0.43 0.114 0.30 0.272
Waistcircumference,cm –0.61 0.015 0.55 0.032 0.65 0.009
Waist/heightratio –0.58 0.023 0.53 0.044 0.55 0.035
Leptin,ng/ml –0.56 0.030 0.31 0.262 0.36 0.191
Adiponectin,mg/ml  0.52 0.049 –0.16 0.568 0.30 0.282
Glucose,mg/dl –0.46 0.088 0.55 0.035 0.30 0.275
Triglycerides,mg/dl –0.40 0.139 0.73 0.002 0.34 0.218











pose transcripts encoding for proteins involved in lipolysis
andlipoproteinmetabolisminsubjects‘resistant’or‘suscepti-





nisms underlying the control of these key lipidmetabolism
processesarestillnotfullyunderstood.Ourdataalsosuggest
thatCES1,arecentlydiscoveredlipase,andAPOEcouldplay
a role in obesity-associated cardiovascular risk factors and
mightbepromisingtargetsinmetabolicsyndrometreatment.
teroltransfer.Infact,thestudyofHuangetal.[38]suggested







up-regulated. It is well known that high levels of plasma
VLDL are associatedwith obesity, type 2 diabetes [42, 43]
andcardiovasculardisease[44].Moreover,VLDLRcanplaya




[47] and triglyceride storage in the adipocyte compared to
wild-type counterparts [46, 48]. Interestingly, apositive cor-
relationbetweenCES1andVLDLRmRNAlevelswasfound
(datanotshown).







isolated adipocytes compared to intact adipose tissue [31].
PreviousstudieshavealsoshownthatAPOEmRNAisfound
indifferentiated3T3-L1adipocytes aswell as inbiopsiesof
humanadiposetissue,butnotinundifferentitated3T3-L1ad-
ipocytes[49],suggestingthatthemaincontributioninAPOE
geneexpressionobserved inadipose tissue fromobese sub-




tant toemphasize that informationobtainedaboutdifferen-
tialgeneexpressionfromthetissueasawholeisrelevant.In-
deed, total adipose tissue has been widely used to identify
genesassociatedwithobesityusingDNAmicroarrays[51,52].










moderatephysical activity),onegroupwas resistant togain
weightandtodevelopmetabolicsyndromefeatures,whilethe




similar up-regulation was found in omental adipose tissue
[23]. These data agree with those of several studies, which
haveshownthatobesityisassociatedwithanimpairedcate-
cholamine-induced lipolysis anda reducedHSLandATGL
expression in adipocytes [24, 25]. However, elevated basal
lipolysishasbeenobserved inobese individualswhich is re-
lated to the bigger fat cell size and to increased levels of
proinflammatorycytokinesinadiposetissue[26,27].
Moreover, in our study a down-regulation of Gia and
CIDEA in obese subjects was found.CIDEA has been as-








expressedin adipocytes and is transcriptionally regulated in
response to changes in nutritional conditions, suggesting a
relevantroleinlipolyticresponsetoextendedfastinginadi-
pocytes [32]. In our study, the positive association between
CES1 and obesity was further supported by the fact that
CES1mRNAexpressionwaspositivelycorrelatedwithwaist
circumference, a recognized marker of adiposity and dys-
lipidemia [33], and with the waist-to-height ratio, a useful
predictorof coronaryheartdisease risk factor [34]. Inaddi-
tion, thepositive correlationbetweenCES1mRNAexpres-
sion and total/HDL cholesterol ratio, a known factor for
cardiovascular risk, suggests thatCES1 couldplaya role in
theimpairedbasal lipolysis inSCAATfromobeseindividu-
als.However, a recentpublicationhas foundno correlation





has been suggested as the cause ofmetabolic syndrome [5,
35].Basedonthefactthattriacylglycerolandcholesterolstor-







recent study evidenced that excess fat accumulation via an
APOE-dependentpathwaymightplayaroleindevelopment
of themetabolic syndrome [39].APOEis secreted by cells
withhighlipidefflux,andithasbeenshowntobeexpressed
highlyinadiposetissue[40,41].Inthesecells,APOEmodu-
lates cellular cholesterol metabolism by facilitating choles-
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pose transcripts encoding for proteins involved in lipolysis
andlipoproteinmetabolisminsubjects‘resistant’or‘suscepti-





nisms underlying the control of these key lipidmetabolism
processesarestillnotfullyunderstood.Ourdataalsosuggest
thatCES1,arecentlydiscoveredlipase,andAPOEcouldplay
a role in obesity-associated cardiovascular risk factors and
mightbepromisingtargetsinmetabolicsyndrometreatment.
teroltransfer.Infact,thestudyofHuangetal.[38]suggested







up-regulated. It is well known that high levels of plasma
VLDL are associatedwith obesity, type 2 diabetes [42, 43]
andcardiovasculardisease[44].Moreover,VLDLRcanplaya




[47] and triglyceride storage in the adipocyte compared to
wild-type counterparts [46, 48]. Interestingly, apositive cor-
relationbetweenCES1andVLDLRmRNAlevelswasfound
(datanotshown).







isolated adipocytes compared to intact adipose tissue [31].
PreviousstudieshavealsoshownthatAPOEmRNAisfound
indifferentiated3T3-L1adipocytes aswell as inbiopsiesof
humanadiposetissue,butnotinundifferentitated3T3-L1ad-
ipocytes[49],suggestingthatthemaincontributioninAPOE
geneexpressionobserved inadipose tissue fromobese sub-




tant toemphasize that informationobtainedaboutdifferen-
tialgeneexpressionfromthetissueasawholeisrelevant.In-
deed, total adipose tissue has been widely used to identify
genesassociatedwithobesityusingDNAmicroarrays[51,52].










moderatephysical activity),onegroupwas resistant togain
weightandtodevelopmetabolicsyndromefeatures,whilethe
other was susceptible to develop obesity and its associated
metaboliccomplications.
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